Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 26, 2024–
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company^TM, today announced that it will be participating in the 26^th Annual H.C. Wainwright Global Investment Conference taking place in New York City September 9-11, 2024.

Jeff Hawkins, Quantum-Si’s Chief Executive Officer, will participate in a fireside chat on Tuesday, September 10^th, at 4:00 PM ET.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantumsi.supremeclients.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240826297214/en/

Investor Contact

Doug Farrell, VP, Investor Relations

[email protected]

Media Contact

Katherine Atkinson, SVP of Commercial Marketing

[email protected]

Source: Quantum-Si Incorporated